Balaji Amines Ltd-$

Balaji Amines Ltd-$

Balaji Amines Ltd has released its Q1 FY27 financial results, showing a strong operational and financial performance with resilient margins. The company has commenced FY27 on a positive note, delivering healthy operational and financial performance despite global macroeconomic headwinds and the West Asia crisis.

Balaji Amines Ltd-$

Balaji Amines Ltd has published the extract of standalone and consolidated un-audited financial results for the quarter ended 30th June, 2026, in newspapers Business Standard and Divya Marathi.

Balaji Amines Ltd-$

Balaji Amines Ltd reported Q1FY27 unaudited financial results with revenue of ₹ 461 crore, EBITDA of ₹ 121 crore, and net profit of ₹ 78 crore. The company also announced the successful commissioning of its 100,000 TPA Dimethyl Ether (DME) plant and plans to commission N-Methyl Morpholine (NMM) and Acetonitrile (ACN) capacity expansion during FY27.

Balaji Amines Ltd-$

Balaji Amines Ltd announced its unaudited standalone and consolidated financial results for the quarter ended 30th June 2026. The company reported revenue from operations of Rs 42,273.75 lakhs, total income of Rs 42,890.54 lakhs, and profit before exceptional items and tax of Rs 9,781.80 lakhs. The company also reported earnings per share of Rs 22.27.

Balaji Amines Ltd-$

Balaji Amines Ltd has announced its unaudited financial results for the quarter ended 30th June, 2026, with a revenue from operations of Rs. 42,273.75 lakhs and a profit for the period of Rs. 7,214.24 lakhs. The company's earnings per share (EPS) for the quarter is Rs. 22.27.